Anguilla vs Jordan: Tuberculosis patients living with HIV receiving antiretroviral therapy
Anguilla
0 patients
in 2016
Jordan
0 patients
in 2021
Anguilla rank
141st
Jordan rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Anguilla
- Jordan
How they compare
Anguilla currently reports 0 patients against 0 patients in Jordan, a difference of 0 patients.
The two have swapped places 2 times across 10 shared years of data; in 2003 it was Jordan ahead.
Anguilla ranks 141st and Jordan ranks 141st of 183 countries.
Jordan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Anguilla | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 0.25 patients | 0.25 patients | Jordan |
| 2010s | 0.1667 patients | 0.3333 patients | 0.1667 patients | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Anguilla or Jordan?
- Anguilla, at 0 patients against 0 patients in Jordan as of 2016.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Anguilla and Jordan?
- 0 patients, with Anguilla ahead.
- How many years of comparable data are there for Anguilla and Jordan?
- 10 years are reported by both, from 2003 to 2016.
- How do Anguilla and Jordan rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Anguilla ranks 141st and Jordan ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.